nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—RBP1—oviduct—ovarian cancer	0.0265	0.111	CbGeAlD
Acitretin—CYP26A1—embryo—ovarian cancer	0.0137	0.0573	CbGeAlD
Acitretin—CYP26A1—decidua—ovarian cancer	0.0105	0.0441	CbGeAlD
Acitretin—CYP26A1—endometrium—ovarian cancer	0.01	0.0419	CbGeAlD
Acitretin—CYP26A1—female reproductive system—ovarian cancer	0.00829	0.0347	CbGeAlD
Acitretin—RBP1—embryo—ovarian cancer	0.00816	0.0342	CbGeAlD
Acitretin—RBP1—epithelium—ovarian cancer	0.00666	0.0279	CbGeAlD
Acitretin—RBP1—uterine cervix—ovarian cancer	0.0066	0.0277	CbGeAlD
Acitretin—RBP1—decidua—ovarian cancer	0.00629	0.0264	CbGeAlD
Acitretin—RARA—myometrium—ovarian cancer	0.00602	0.0252	CbGeAlD
Acitretin—RBP1—gonad—ovarian cancer	0.00554	0.0232	CbGeAlD
Acitretin—RBP1—uterus—ovarian cancer	0.0055	0.0231	CbGeAlD
Acitretin—RXRB—decidua—ovarian cancer	0.00535	0.0224	CbGeAlD
Acitretin—RXRA—female reproductive system—ovarian cancer	0.0051	0.0214	CbGeAlD
Acitretin—RBP1—female reproductive system—ovarian cancer	0.00495	0.0207	CbGeAlD
Acitretin—RARG—decidua—ovarian cancer	0.00475	0.0199	CbGeAlD
Acitretin—RXRA—female gonad—ovarian cancer	0.00464	0.0194	CbGeAlD
Acitretin—RARB—female reproductive system—ovarian cancer	0.00458	0.0192	CbGeAlD
Acitretin—RBP1—female gonad—ovarian cancer	0.0045	0.0189	CbGeAlD
Acitretin—RBP1—vagina—ovarian cancer	0.00447	0.0187	CbGeAlD
Acitretin—RARA—decidua—ovarian cancer	0.00447	0.0187	CbGeAlD
Acitretin—RARA—endometrium—ovarian cancer	0.00424	0.0178	CbGeAlD
Acitretin—RARB—female gonad—ovarian cancer	0.00417	0.0175	CbGeAlD
Acitretin—RARG—uterus—ovarian cancer	0.00415	0.0174	CbGeAlD
Acitretin—RARB—vagina—ovarian cancer	0.00414	0.0173	CbGeAlD
Acitretin—RBP1—testis—ovarian cancer	0.00399	0.0167	CbGeAlD
Acitretin—RARA—gonad—ovarian cancer	0.00393	0.0165	CbGeAlD
Acitretin—RARA—uterus—ovarian cancer	0.00391	0.0164	CbGeAlD
Acitretin—RXRB—female gonad—ovarian cancer	0.00383	0.016	CbGeAlD
Acitretin—RXRB—vagina—ovarian cancer	0.0038	0.0159	CbGeAlD
Acitretin—RARG—female reproductive system—ovarian cancer	0.00373	0.0156	CbGeAlD
Acitretin—RXRG—testis—ovarian cancer	0.00361	0.0151	CbGeAlD
Acitretin—RARA—female reproductive system—ovarian cancer	0.00351	0.0147	CbGeAlD
Acitretin—RARG—female gonad—ovarian cancer	0.0034	0.0142	CbGeAlD
Acitretin—RXRB—testis—ovarian cancer	0.0034	0.0142	CbGeAlD
Acitretin—RARG—vagina—ovarian cancer	0.00338	0.0141	CbGeAlD
Acitretin—RARA—bone marrow—ovarian cancer	0.00331	0.0139	CbGeAlD
Acitretin—RARA—female gonad—ovarian cancer	0.0032	0.0134	CbGeAlD
Acitretin—RARG—testis—ovarian cancer	0.00301	0.0126	CbGeAlD
Acitretin—RBP1—lymph node—ovarian cancer	0.00289	0.0121	CbGeAlD
Acitretin—RARA—testis—ovarian cancer	0.00283	0.0119	CbGeAlD
Acitretin—RARB—lymph node—ovarian cancer	0.00268	0.0112	CbGeAlD
Acitretin—RARG—lymph node—ovarian cancer	0.00218	0.00915	CbGeAlD
Acitretin—RARA—lymph node—ovarian cancer	0.00205	0.0086	CbGeAlD
Acitretin—ALB—testis—ovarian cancer	0.0016	0.00669	CbGeAlD
Acitretin—ALB—lymph node—ovarian cancer	0.00116	0.00485	CbGeAlD
Acitretin—Rash—Melphalan—ovarian cancer	0.000325	0.000743	CcSEcCtD
Acitretin—Dermatitis—Melphalan—ovarian cancer	0.000325	0.000742	CcSEcCtD
Acitretin—Chills—Docetaxel—ovarian cancer	0.000324	0.000741	CcSEcCtD
Acitretin—Cough—Paclitaxel—ovarian cancer	0.000324	0.00074	CcSEcCtD
Acitretin—Asthenia—Vinorelbine—ovarian cancer	0.000323	0.000738	CcSEcCtD
Acitretin—Dry skin—Epirubicin—ovarian cancer	0.000323	0.000738	CcSEcCtD
Acitretin—Migraine—Doxorubicin—ovarian cancer	0.000321	0.000733	CcSEcCtD
Acitretin—Alopecia—Docetaxel—ovarian cancer	0.000319	0.00073	CcSEcCtD
Acitretin—Pruritus—Vinorelbine—ovarian cancer	0.000319	0.000728	CcSEcCtD
Acitretin—Arthralgia—Paclitaxel—ovarian cancer	0.000316	0.000722	CcSEcCtD
Acitretin—Chest pain—Paclitaxel—ovarian cancer	0.000316	0.000722	CcSEcCtD
Acitretin—Myalgia—Paclitaxel—ovarian cancer	0.000316	0.000722	CcSEcCtD
Acitretin—Anxiety—Paclitaxel—ovarian cancer	0.000315	0.000719	CcSEcCtD
Acitretin—Erythema—Docetaxel—ovarian cancer	0.000315	0.000719	CcSEcCtD
Acitretin—Nausea—Topotecan—ovarian cancer	0.000313	0.000714	CcSEcCtD
Acitretin—Discomfort—Paclitaxel—ovarian cancer	0.000312	0.000713	CcSEcCtD
Acitretin—Gastritis—Epirubicin—ovarian cancer	0.000312	0.000712	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000311	0.00071	CcSEcCtD
Acitretin—Muscular weakness—Epirubicin—ovarian cancer	0.000311	0.00071	CcSEcCtD
Acitretin—Dry mouth—Paclitaxel—ovarian cancer	0.000309	0.000706	CcSEcCtD
Acitretin—Diarrhoea—Vinorelbine—ovarian cancer	0.000308	0.000704	CcSEcCtD
Acitretin—Dysgeusia—Docetaxel—ovarian cancer	0.000308	0.000704	CcSEcCtD
Acitretin—Nausea—Melphalan—ovarian cancer	0.000306	0.0007	CcSEcCtD
Acitretin—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000305	0.000698	CcSEcCtD
Acitretin—Back pain—Docetaxel—ovarian cancer	0.000304	0.000695	CcSEcCtD
Acitretin—Oedema—Paclitaxel—ovarian cancer	0.000303	0.000692	CcSEcCtD
Acitretin—Muscle spasms—Docetaxel—ovarian cancer	0.000302	0.000691	CcSEcCtD
Acitretin—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000301	0.000688	CcSEcCtD
Acitretin—Infection—Paclitaxel—ovarian cancer	0.000301	0.000688	CcSEcCtD
Acitretin—Dry skin—Doxorubicin—ovarian cancer	0.000299	0.000683	CcSEcCtD
Acitretin—Pancreatitis—Epirubicin—ovarian cancer	0.000299	0.000682	CcSEcCtD
Acitretin—Dizziness—Vinorelbine—ovarian cancer	0.000298	0.00068	CcSEcCtD
Acitretin—Skin disorder—Paclitaxel—ovarian cancer	0.000294	0.000672	CcSEcCtD
Acitretin—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000293	0.000669	CcSEcCtD
Acitretin—Pancytopenia—Epirubicin—ovarian cancer	0.000289	0.000661	CcSEcCtD
Acitretin—Anorexia—Paclitaxel—ovarian cancer	0.000289	0.00066	CcSEcCtD
Acitretin—Gastritis—Doxorubicin—ovarian cancer	0.000289	0.000659	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000288	0.000657	CcSEcCtD
Acitretin—Muscular weakness—Doxorubicin—ovarian cancer	0.000288	0.000657	CcSEcCtD
Acitretin—Vomiting—Vinorelbine—ovarian cancer	0.000286	0.000654	CcSEcCtD
Acitretin—Dysuria—Epirubicin—ovarian cancer	0.000285	0.000651	CcSEcCtD
Acitretin—Rash—Vinorelbine—ovarian cancer	0.000284	0.000649	CcSEcCtD
Acitretin—Dermatitis—Vinorelbine—ovarian cancer	0.000284	0.000648	CcSEcCtD
Acitretin—Headache—Vinorelbine—ovarian cancer	0.000282	0.000645	CcSEcCtD
Acitretin—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000278	0.000635	CcSEcCtD
Acitretin—Weight increased—Epirubicin—ovarian cancer	0.000277	0.000633	CcSEcCtD
Acitretin—Pancreatitis—Doxorubicin—ovarian cancer	0.000276	0.000631	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000276	0.000631	CcSEcCtD
Acitretin—Weight decreased—Epirubicin—ovarian cancer	0.000276	0.000629	CcSEcCtD
Acitretin—Cough—Docetaxel—ovarian cancer	0.000275	0.000627	CcSEcCtD
Acitretin—Insomnia—Paclitaxel—ovarian cancer	0.000274	0.000626	CcSEcCtD
Acitretin—Paraesthesia—Paclitaxel—ovarian cancer	0.000272	0.000621	CcSEcCtD
Acitretin—Somnolence—Paclitaxel—ovarian cancer	0.000269	0.000615	CcSEcCtD
Acitretin—Chest pain—Docetaxel—ovarian cancer	0.000268	0.000612	CcSEcCtD
Acitretin—Arthralgia—Docetaxel—ovarian cancer	0.000268	0.000612	CcSEcCtD
Acitretin—Myalgia—Docetaxel—ovarian cancer	0.000268	0.000612	CcSEcCtD
Acitretin—Pancytopenia—Doxorubicin—ovarian cancer	0.000268	0.000611	CcSEcCtD
Acitretin—Nausea—Vinorelbine—ovarian cancer	0.000268	0.000611	CcSEcCtD
Acitretin—Dyspepsia—Paclitaxel—ovarian cancer	0.000267	0.000609	CcSEcCtD
Acitretin—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000266	0.000608	CcSEcCtD
Acitretin—Stomatitis—Epirubicin—ovarian cancer	0.000265	0.000605	CcSEcCtD
Acitretin—Jaundice—Epirubicin—ovarian cancer	0.000265	0.000605	CcSEcCtD
Acitretin—Urinary tract infection—Epirubicin—ovarian cancer	0.000264	0.000603	CcSEcCtD
Acitretin—Conjunctivitis—Epirubicin—ovarian cancer	0.000264	0.000603	CcSEcCtD
Acitretin—Dysuria—Doxorubicin—ovarian cancer	0.000263	0.000602	CcSEcCtD
Acitretin—Decreased appetite—Paclitaxel—ovarian cancer	0.000263	0.000602	CcSEcCtD
Acitretin—Dry mouth—Docetaxel—ovarian cancer	0.000262	0.000598	CcSEcCtD
Acitretin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000262	0.000598	CcSEcCtD
Acitretin—Fatigue—Paclitaxel—ovarian cancer	0.000261	0.000597	CcSEcCtD
Acitretin—Pain—Paclitaxel—ovarian cancer	0.000259	0.000592	CcSEcCtD
Acitretin—Constipation—Paclitaxel—ovarian cancer	0.000259	0.000592	CcSEcCtD
Acitretin—Haematuria—Epirubicin—ovarian cancer	0.000259	0.000592	CcSEcCtD
Acitretin—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000257	0.000588	CcSEcCtD
Acitretin—Oedema—Docetaxel—ovarian cancer	0.000257	0.000587	CcSEcCtD
Acitretin—Weight increased—Doxorubicin—ovarian cancer	0.000256	0.000586	CcSEcCtD
Acitretin—Epistaxis—Epirubicin—ovarian cancer	0.000256	0.000585	CcSEcCtD
Acitretin—Infection—Docetaxel—ovarian cancer	0.000255	0.000583	CcSEcCtD
Acitretin—Weight decreased—Doxorubicin—ovarian cancer	0.000255	0.000582	CcSEcCtD
Acitretin—Sinusitis—Epirubicin—ovarian cancer	0.000255	0.000582	CcSEcCtD
Acitretin—Feeling abnormal—Paclitaxel—ovarian cancer	0.00025	0.00057	CcSEcCtD
Acitretin—Skin disorder—Docetaxel—ovarian cancer	0.000249	0.00057	CcSEcCtD
Acitretin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000248	0.000566	CcSEcCtD
Acitretin—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000246	0.000563	CcSEcCtD
Acitretin—Haemoglobin—Epirubicin—ovarian cancer	0.000245	0.00056	CcSEcCtD
Acitretin—Jaundice—Doxorubicin—ovarian cancer	0.000245	0.00056	CcSEcCtD
Acitretin—Stomatitis—Doxorubicin—ovarian cancer	0.000245	0.00056	CcSEcCtD
Acitretin—Anorexia—Docetaxel—ovarian cancer	0.000245	0.000559	CcSEcCtD
Acitretin—Rhinitis—Epirubicin—ovarian cancer	0.000244	0.000558	CcSEcCtD
Acitretin—Urinary tract infection—Doxorubicin—ovarian cancer	0.000244	0.000558	CcSEcCtD
Acitretin—Conjunctivitis—Doxorubicin—ovarian cancer	0.000244	0.000558	CcSEcCtD
Acitretin—Haemorrhage—Epirubicin—ovarian cancer	0.000244	0.000557	CcSEcCtD
Acitretin—Hepatitis—Epirubicin—ovarian cancer	0.000244	0.000557	CcSEcCtD
Acitretin—Hypoaesthesia—Epirubicin—ovarian cancer	0.000243	0.000554	CcSEcCtD
Acitretin—Pharyngitis—Epirubicin—ovarian cancer	0.000242	0.000553	CcSEcCtD
Acitretin—Urticaria—Paclitaxel—ovarian cancer	0.000241	0.00055	CcSEcCtD
Acitretin—Oedema peripheral—Epirubicin—ovarian cancer	0.00024	0.000549	CcSEcCtD
Acitretin—Haematuria—Doxorubicin—ovarian cancer	0.00024	0.000547	CcSEcCtD
Acitretin—Body temperature increased—Paclitaxel—ovarian cancer	0.000239	0.000547	CcSEcCtD
Acitretin—Abdominal pain—Paclitaxel—ovarian cancer	0.000239	0.000547	CcSEcCtD
Acitretin—Epistaxis—Doxorubicin—ovarian cancer	0.000237	0.000541	CcSEcCtD
Acitretin—Sinusitis—Doxorubicin—ovarian cancer	0.000236	0.000539	CcSEcCtD
Acitretin—Visual impairment—Epirubicin—ovarian cancer	0.000235	0.000537	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000234	0.000534	CcSEcCtD
Acitretin—Insomnia—Docetaxel—ovarian cancer	0.000232	0.000531	CcSEcCtD
Acitretin—Paraesthesia—Docetaxel—ovarian cancer	0.000231	0.000527	CcSEcCtD
Acitretin—Somnolence—Docetaxel—ovarian cancer	0.000228	0.000522	CcSEcCtD
Acitretin—Eye disorder—Epirubicin—ovarian cancer	0.000228	0.00052	CcSEcCtD
Acitretin—Tinnitus—Epirubicin—ovarian cancer	0.000227	0.000519	CcSEcCtD
Acitretin—Haemoglobin—Doxorubicin—ovarian cancer	0.000227	0.000518	CcSEcCtD
Acitretin—Flushing—Epirubicin—ovarian cancer	0.000226	0.000517	CcSEcCtD
Acitretin—Rhinitis—Doxorubicin—ovarian cancer	0.000226	0.000517	CcSEcCtD
Acitretin—Dyspepsia—Docetaxel—ovarian cancer	0.000226	0.000516	CcSEcCtD
Acitretin—Haemorrhage—Doxorubicin—ovarian cancer	0.000226	0.000515	CcSEcCtD
Acitretin—Hepatitis—Doxorubicin—ovarian cancer	0.000226	0.000515	CcSEcCtD
Acitretin—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000224	0.000513	CcSEcCtD
Acitretin—Pharyngitis—Doxorubicin—ovarian cancer	0.000224	0.000511	CcSEcCtD
Acitretin—Decreased appetite—Docetaxel—ovarian cancer	0.000223	0.00051	CcSEcCtD
Acitretin—Hypersensitivity—Paclitaxel—ovarian cancer	0.000223	0.00051	CcSEcCtD
Acitretin—Oedema peripheral—Doxorubicin—ovarian cancer	0.000222	0.000508	CcSEcCtD
Acitretin—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000222	0.000506	CcSEcCtD
Acitretin—Fatigue—Docetaxel—ovarian cancer	0.000221	0.000506	CcSEcCtD
Acitretin—Angiopathy—Epirubicin—ovarian cancer	0.000221	0.000505	CcSEcCtD
Acitretin—Immune system disorder—Epirubicin—ovarian cancer	0.00022	0.000503	CcSEcCtD
Acitretin—Pain—Docetaxel—ovarian cancer	0.00022	0.000502	CcSEcCtD
Acitretin—Constipation—Docetaxel—ovarian cancer	0.00022	0.000502	CcSEcCtD
Acitretin—Chills—Epirubicin—ovarian cancer	0.000219	0.0005	CcSEcCtD
Acitretin—Visual impairment—Doxorubicin—ovarian cancer	0.000217	0.000497	CcSEcCtD
Acitretin—Asthenia—Paclitaxel—ovarian cancer	0.000217	0.000497	CcSEcCtD
Acitretin—Alopecia—Epirubicin—ovarian cancer	0.000215	0.000492	CcSEcCtD
Acitretin—Pruritus—Paclitaxel—ovarian cancer	0.000214	0.00049	CcSEcCtD
Acitretin—Erythema—Epirubicin—ovarian cancer	0.000212	0.000485	CcSEcCtD
Acitretin—Feeling abnormal—Docetaxel—ovarian cancer	0.000212	0.000483	CcSEcCtD
Acitretin—Eye disorder—Doxorubicin—ovarian cancer	0.000211	0.000482	CcSEcCtD
Acitretin—Tinnitus—Doxorubicin—ovarian cancer	0.00021	0.00048	CcSEcCtD
Acitretin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00021	0.00048	CcSEcCtD
Acitretin—Flushing—Doxorubicin—ovarian cancer	0.000209	0.000478	CcSEcCtD
Acitretin—Tension—Epirubicin—ovarian cancer	0.000208	0.000476	CcSEcCtD
Acitretin—Dysgeusia—Epirubicin—ovarian cancer	0.000208	0.000475	CcSEcCtD
Acitretin—Diarrhoea—Paclitaxel—ovarian cancer	0.000207	0.000474	CcSEcCtD
Acitretin—Nervousness—Epirubicin—ovarian cancer	0.000206	0.000471	CcSEcCtD
Acitretin—Back pain—Epirubicin—ovarian cancer	0.000205	0.000469	CcSEcCtD
Acitretin—Angiopathy—Doxorubicin—ovarian cancer	0.000205	0.000468	CcSEcCtD
Acitretin—Muscle spasms—Epirubicin—ovarian cancer	0.000204	0.000466	CcSEcCtD
Acitretin—Immune system disorder—Doxorubicin—ovarian cancer	0.000204	0.000465	CcSEcCtD
Acitretin—Abdominal pain—Docetaxel—ovarian cancer	0.000203	0.000464	CcSEcCtD
Acitretin—Body temperature increased—Docetaxel—ovarian cancer	0.000203	0.000464	CcSEcCtD
Acitretin—Chills—Doxorubicin—ovarian cancer	0.000202	0.000462	CcSEcCtD
Acitretin—Dizziness—Paclitaxel—ovarian cancer	0.0002	0.000458	CcSEcCtD
Acitretin—Vision blurred—Epirubicin—ovarian cancer	0.0002	0.000457	CcSEcCtD
Acitretin—Alopecia—Doxorubicin—ovarian cancer	0.000199	0.000455	CcSEcCtD
Acitretin—Ill-defined disorder—Epirubicin—ovarian cancer	0.000197	0.00045	CcSEcCtD
Acitretin—Erythema—Doxorubicin—ovarian cancer	0.000196	0.000449	CcSEcCtD
Acitretin—Tension—Doxorubicin—ovarian cancer	0.000193	0.00044	CcSEcCtD
Acitretin—Vomiting—Paclitaxel—ovarian cancer	0.000193	0.00044	CcSEcCtD
Acitretin—Dysgeusia—Doxorubicin—ovarian cancer	0.000192	0.000439	CcSEcCtD
Acitretin—Malaise—Epirubicin—ovarian cancer	0.000191	0.000437	CcSEcCtD
Acitretin—Rash—Paclitaxel—ovarian cancer	0.000191	0.000436	CcSEcCtD
Acitretin—Dermatitis—Paclitaxel—ovarian cancer	0.000191	0.000436	CcSEcCtD
Acitretin—Nervousness—Doxorubicin—ovarian cancer	0.000191	0.000436	CcSEcCtD
Acitretin—Back pain—Doxorubicin—ovarian cancer	0.00019	0.000434	CcSEcCtD
Acitretin—Headache—Paclitaxel—ovarian cancer	0.00019	0.000434	CcSEcCtD
Acitretin—Hypersensitivity—Docetaxel—ovarian cancer	0.000189	0.000432	CcSEcCtD
Acitretin—Muscle spasms—Doxorubicin—ovarian cancer	0.000189	0.000431	CcSEcCtD
Acitretin—Cough—Epirubicin—ovarian cancer	0.000185	0.000423	CcSEcCtD
Acitretin—Vision blurred—Doxorubicin—ovarian cancer	0.000185	0.000423	CcSEcCtD
Acitretin—Asthenia—Docetaxel—ovarian cancer	0.000184	0.000421	CcSEcCtD
Acitretin—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000182	0.000416	CcSEcCtD
Acitretin—Pruritus—Docetaxel—ovarian cancer	0.000182	0.000415	CcSEcCtD
Acitretin—Arthralgia—Epirubicin—ovarian cancer	0.000181	0.000413	CcSEcCtD
Acitretin—Chest pain—Epirubicin—ovarian cancer	0.000181	0.000413	CcSEcCtD
Acitretin—Myalgia—Epirubicin—ovarian cancer	0.000181	0.000413	CcSEcCtD
Acitretin—Anxiety—Epirubicin—ovarian cancer	0.00018	0.000411	CcSEcCtD
Acitretin—Nausea—Paclitaxel—ovarian cancer	0.00018	0.000411	CcSEcCtD
Acitretin—Discomfort—Epirubicin—ovarian cancer	0.000178	0.000408	CcSEcCtD
Acitretin—Malaise—Doxorubicin—ovarian cancer	0.000177	0.000405	CcSEcCtD
Acitretin—Dry mouth—Epirubicin—ovarian cancer	0.000177	0.000404	CcSEcCtD
Acitretin—Diarrhoea—Docetaxel—ovarian cancer	0.000176	0.000401	CcSEcCtD
Acitretin—Oedema—Epirubicin—ovarian cancer	0.000173	0.000396	CcSEcCtD
Acitretin—Infection—Epirubicin—ovarian cancer	0.000172	0.000393	CcSEcCtD
Acitretin—Cough—Doxorubicin—ovarian cancer	0.000171	0.000391	CcSEcCtD
Acitretin—Dizziness—Docetaxel—ovarian cancer	0.00017	0.000388	CcSEcCtD
Acitretin—Skin disorder—Epirubicin—ovarian cancer	0.000168	0.000384	CcSEcCtD
Acitretin—Hyperhidrosis—Epirubicin—ovarian cancer	0.000167	0.000383	CcSEcCtD
Acitretin—Chest pain—Doxorubicin—ovarian cancer	0.000167	0.000382	CcSEcCtD
Acitretin—Arthralgia—Doxorubicin—ovarian cancer	0.000167	0.000382	CcSEcCtD
Acitretin—Myalgia—Doxorubicin—ovarian cancer	0.000167	0.000382	CcSEcCtD
Acitretin—Anxiety—Doxorubicin—ovarian cancer	0.000167	0.000381	CcSEcCtD
Acitretin—Discomfort—Doxorubicin—ovarian cancer	0.000165	0.000377	CcSEcCtD
Acitretin—Anorexia—Epirubicin—ovarian cancer	0.000165	0.000377	CcSEcCtD
Acitretin—RXRG—Gene Expression—PARP1—ovarian cancer	0.000164	0.000508	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	0.000164	0.000506	CbGpPWpGaD
Acitretin—Dry mouth—Doxorubicin—ovarian cancer	0.000163	0.000374	CcSEcCtD
Acitretin—Vomiting—Docetaxel—ovarian cancer	0.000163	0.000373	CcSEcCtD
Acitretin—Rash—Docetaxel—ovarian cancer	0.000162	0.00037	CcSEcCtD
Acitretin—Dermatitis—Docetaxel—ovarian cancer	0.000162	0.00037	CcSEcCtD
Acitretin—RARB—Gene Expression—PARP1—ovarian cancer	0.000161	0.000498	CbGpPWpGaD
Acitretin—Headache—Docetaxel—ovarian cancer	0.000161	0.000367	CcSEcCtD
Acitretin—CYP26A1—Metabolism—SLC2A1—ovarian cancer	0.000161	0.000497	CbGpPWpGaD
Acitretin—Oedema—Doxorubicin—ovarian cancer	0.00016	0.000366	CcSEcCtD
Acitretin—Infection—Doxorubicin—ovarian cancer	0.000159	0.000364	CcSEcCtD
Acitretin—RBP1—Disease—TERT—ovarian cancer	0.000159	0.000492	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	0.000158	0.00049	CbGpPWpGaD
Acitretin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000158	0.00036	CcSEcCtD
Acitretin—Insomnia—Epirubicin—ovarian cancer	0.000157	0.000358	CcSEcCtD
Acitretin—Skin disorder—Doxorubicin—ovarian cancer	0.000156	0.000356	CcSEcCtD
Acitretin—Paraesthesia—Epirubicin—ovarian cancer	0.000156	0.000355	CcSEcCtD
Acitretin—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000155	0.000354	CcSEcCtD
Acitretin—RXRB—Gene Expression—PARP1—ovarian cancer	0.000154	0.000477	CbGpPWpGaD
Acitretin—RARA—Gene Expression—PARP1—ovarian cancer	0.000154	0.000477	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—CYP1B1—ovarian cancer	0.000154	0.000476	CbGpPWpGaD
Acitretin—Somnolence—Epirubicin—ovarian cancer	0.000154	0.000352	CcSEcCtD
Acitretin—ALB—Platelet activation, signaling and aggregation—SPARC—ovarian cancer	0.000153	0.000474	CbGpPWpGaD
Acitretin—Anorexia—Doxorubicin—ovarian cancer	0.000153	0.000349	CcSEcCtD
Acitretin—Nausea—Docetaxel—ovarian cancer	0.000153	0.000348	CcSEcCtD
Acitretin—Dyspepsia—Epirubicin—ovarian cancer	0.000152	0.000348	CcSEcCtD
Acitretin—Decreased appetite—Epirubicin—ovarian cancer	0.000151	0.000344	CcSEcCtD
Acitretin—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.00015	0.000342	CcSEcCtD
Acitretin—Fatigue—Epirubicin—ovarian cancer	0.000149	0.000341	CcSEcCtD
Acitretin—Pain—Epirubicin—ovarian cancer	0.000148	0.000338	CcSEcCtD
Acitretin—Constipation—Epirubicin—ovarian cancer	0.000148	0.000338	CcSEcCtD
Acitretin—ALB—Hemostasis—RAD51C—ovarian cancer	0.000148	0.000457	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—STAT3—ovarian cancer	0.000147	0.000455	CbGpPWpGaD
Acitretin—RBP1—Disease—CAV1—ovarian cancer	0.000147	0.000455	CbGpPWpGaD
Acitretin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000146	0.000334	CcSEcCtD
Acitretin—RARG—Gene Expression—PPP2R1A—ovarian cancer	0.000146	0.00045	CbGpPWpGaD
Acitretin—Insomnia—Doxorubicin—ovarian cancer	0.000145	0.000331	CcSEcCtD
Acitretin—Paraesthesia—Doxorubicin—ovarian cancer	0.000144	0.000329	CcSEcCtD
Acitretin—Feeling abnormal—Epirubicin—ovarian cancer	0.000143	0.000326	CcSEcCtD
Acitretin—Somnolence—Doxorubicin—ovarian cancer	0.000142	0.000325	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	0.000142	0.000439	CbGpPWpGaD
Acitretin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000142	0.000324	CcSEcCtD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000141	0.000436	CbGpPWpGaD
Acitretin—Dyspepsia—Doxorubicin—ovarian cancer	0.000141	0.000322	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—PPP2R1A—ovarian cancer	0.00014	0.000433	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	0.00014	0.000431	CbGpPWpGaD
Acitretin—RBP1—Disease—IL6ST—ovarian cancer	0.00014	0.000431	CbGpPWpGaD
Acitretin—Decreased appetite—Doxorubicin—ovarian cancer	0.000139	0.000318	CcSEcCtD
Acitretin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000138	0.000316	CcSEcCtD
Acitretin—Fatigue—Doxorubicin—ovarian cancer	0.000138	0.000316	CcSEcCtD
Acitretin—Urticaria—Epirubicin—ovarian cancer	0.000138	0.000314	CcSEcCtD
Acitretin—ALB—Folate Metabolism—IL2—ovarian cancer	0.000137	0.000424	CbGpPWpGaD
Acitretin—Pain—Doxorubicin—ovarian cancer	0.000137	0.000313	CcSEcCtD
Acitretin—Constipation—Doxorubicin—ovarian cancer	0.000137	0.000313	CcSEcCtD
Acitretin—Abdominal pain—Epirubicin—ovarian cancer	0.000137	0.000313	CcSEcCtD
Acitretin—Body temperature increased—Epirubicin—ovarian cancer	0.000137	0.000313	CcSEcCtD
Acitretin—CYP26A1—Metabolism—PPP2R1A—ovarian cancer	0.000137	0.000423	CbGpPWpGaD
Acitretin—RBP1—Disease—APC—ovarian cancer	0.000134	0.000414	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	0.000134	0.000414	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—PPP2R1A—ovarian cancer	0.000133	0.000412	CbGpPWpGaD
Acitretin—Feeling abnormal—Doxorubicin—ovarian cancer	0.000132	0.000302	CcSEcCtD
Acitretin—RXRA—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000132	0.000408	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYTB—ovarian cancer	0.000132	0.000407	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	0.000131	0.000406	CbGpPWpGaD
Acitretin—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000131	0.000299	CcSEcCtD
Acitretin—RARB—Gene Expression—PPP2R1A—ovarian cancer	0.000131	0.000404	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	0.000129	0.000398	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000129	0.000397	CbGpPWpGaD
Acitretin—Hypersensitivity—Epirubicin—ovarian cancer	0.000128	0.000292	CcSEcCtD
Acitretin—RXRA—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000128	0.000394	CbGpPWpGaD
Acitretin—Urticaria—Doxorubicin—ovarian cancer	0.000127	0.000291	CcSEcCtD
Acitretin—CYP26A1—Metabolism—ABCB1—ovarian cancer	0.000127	0.000392	CbGpPWpGaD
Acitretin—Body temperature increased—Doxorubicin—ovarian cancer	0.000127	0.000289	CcSEcCtD
Acitretin—Abdominal pain—Doxorubicin—ovarian cancer	0.000127	0.000289	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	0.000125	0.000387	CbGpPWpGaD
Acitretin—RARA—Gene Expression—PPP2R1A—ovarian cancer	0.000125	0.000387	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—PPP2R1A—ovarian cancer	0.000125	0.000387	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—TYMS—ovarian cancer	0.000125	0.000385	CbGpPWpGaD
Acitretin—Asthenia—Epirubicin—ovarian cancer	0.000124	0.000284	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	0.000124	0.000384	CbGpPWpGaD
Acitretin—Pruritus—Epirubicin—ovarian cancer	0.000123	0.00028	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	0.000121	0.000374	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000119	0.000368	CbGpPWpGaD
Acitretin—ALB—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.000119	0.000366	CbGpPWpGaD
Acitretin—Diarrhoea—Epirubicin—ovarian cancer	0.000118	0.000271	CcSEcCtD
Acitretin—Hypersensitivity—Doxorubicin—ovarian cancer	0.000118	0.00027	CcSEcCtD
Acitretin—RBP1—Disease—PIK3CD—ovarian cancer	0.000118	0.000364	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000118	0.000364	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PPP1CC—ovarian cancer	0.000115	0.000355	CbGpPWpGaD
Acitretin—RXRA—Metabolism—BRIP1—ovarian cancer	0.000115	0.000355	CbGpPWpGaD
Acitretin—Asthenia—Doxorubicin—ovarian cancer	0.000115	0.000263	CcSEcCtD
Acitretin—Dizziness—Epirubicin—ovarian cancer	0.000115	0.000262	CcSEcCtD
Acitretin—ALB—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000114	0.000354	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000114	0.000353	CbGpPWpGaD
Acitretin—Pruritus—Doxorubicin—ovarian cancer	0.000113	0.000259	CcSEcCtD
Acitretin—RARG—Generic Transcription Pathway—MYC—ovarian cancer	0.000111	0.000344	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TERT—ovarian cancer	0.000111	0.000344	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—SOD1—ovarian cancer	0.000111	0.000344	CbGpPWpGaD
Acitretin—Vomiting—Epirubicin—ovarian cancer	0.00011	0.000252	CcSEcCtD
Acitretin—Diarrhoea—Doxorubicin—ovarian cancer	0.00011	0.00025	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	0.000109	0.000338	CbGpPWpGaD
Acitretin—Rash—Epirubicin—ovarian cancer	0.000109	0.000249	CcSEcCtD
Acitretin—Dermatitis—Epirubicin—ovarian cancer	0.000109	0.000249	CcSEcCtD
Acitretin—Headache—Epirubicin—ovarian cancer	0.000108	0.000248	CcSEcCtD
Acitretin—Dizziness—Doxorubicin—ovarian cancer	0.000106	0.000242	CcSEcCtD
Acitretin—RBP1—Disease—ERBB2—ovarian cancer	0.000104	0.000322	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	0.000103	0.00032	CbGpPWpGaD
Acitretin—RARG—Gene Expression—ESR1—ovarian cancer	0.000103	0.000319	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CAV1—ovarian cancer	0.000103	0.000319	CbGpPWpGaD
Acitretin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—ovarian cancer	0.000103	0.000318	CbGpPWpGaD
Acitretin—Nausea—Epirubicin—ovarian cancer	0.000103	0.000235	CcSEcCtD
Acitretin—RXRA—Adipogenesis—IL6—ovarian cancer	0.000103	0.000318	CbGpPWpGaD
Acitretin—RBP1—Disease—MTOR—ovarian cancer	0.000103	0.000317	CbGpPWpGaD
Acitretin—RBP1—Disease—PIK3CB—ovarian cancer	0.000103	0.000317	CbGpPWpGaD
Acitretin—RXRG—Generic Transcription Pathway—MYC—ovarian cancer	0.000102	0.000315	CbGpPWpGaD
Acitretin—Vomiting—Doxorubicin—ovarian cancer	0.000102	0.000233	CcSEcCtD
Acitretin—Rash—Doxorubicin—ovarian cancer	0.000101	0.000231	CcSEcCtD
Acitretin—Dermatitis—Doxorubicin—ovarian cancer	0.000101	0.000231	CcSEcCtD
Acitretin—RXRA—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000101	0.000311	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	0.000101	0.000311	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—CAV1—ovarian cancer	0.0001	0.000311	CbGpPWpGaD
Acitretin—Headache—Doxorubicin—ovarian cancer	0.0001	0.000229	CcSEcCtD
Acitretin—ALB—Platelet degranulation—VEGFA—ovarian cancer	0.0001	0.000309	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—MYC—ovarian cancer	0.0001	0.000309	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—ESR1—ovarian cancer	9.93e-05	0.000307	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—YAP1—ovarian cancer	9.92e-05	0.000306	CbGpPWpGaD
Acitretin—ALB—Vitamin B12 Metabolism—IL6—ovarian cancer	9.92e-05	0.000306	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	9.84e-05	0.000304	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	9.84e-05	0.000304	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IL6ST—ovarian cancer	9.77e-05	0.000302	CbGpPWpGaD
Acitretin—RBP1—Disease—CDKN1B—ovarian cancer	9.64e-05	0.000298	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—ESR1—ovarian cancer	9.6e-05	0.000297	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—MYC—ovarian cancer	9.59e-05	0.000296	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—MYC—ovarian cancer	9.59e-05	0.000296	CbGpPWpGaD
Acitretin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—ovarian cancer	9.53e-05	0.000294	CbGpPWpGaD
Acitretin—Nausea—Doxorubicin—ovarian cancer	9.52e-05	0.000217	CcSEcCtD
Acitretin—RXRG—Gene Expression—ESR1—ovarian cancer	9.44e-05	0.000292	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—APC—ovarian cancer	9.39e-05	0.00029	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CG—ovarian cancer	9.39e-05	0.00029	CbGpPWpGaD
Acitretin—ALB—Metabolism—NME2—ovarian cancer	9.31e-05	0.000288	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	9.29e-05	0.000287	CbGpPWpGaD
Acitretin—RARB—Gene Expression—ESR1—ovarian cancer	9.25e-05	0.000286	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CG—ovarian cancer	9.15e-05	0.000283	CbGpPWpGaD
Acitretin—RBP1—Disease—CTNNB1—ovarian cancer	9.11e-05	0.000281	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MET—ovarian cancer	9.08e-05	0.000281	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—TUBB3—ovarian cancer	9.03e-05	0.000279	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—IL6ST—ovarian cancer	8.89e-05	0.000275	CbGpPWpGaD
Acitretin—RBP1—Disease—PTEN—ovarian cancer	8.88e-05	0.000274	CbGpPWpGaD
Acitretin—RARA—Gene Expression—ESR1—ovarian cancer	8.87e-05	0.000274	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—ESR1—ovarian cancer	8.87e-05	0.000274	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—TP53—ovarian cancer	8.81e-05	0.000272	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—PGR—ovarian cancer	8.66e-05	0.000268	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	8.54e-05	0.000264	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	8.38e-05	0.000259	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	8.26e-05	0.000255	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CD—ovarian cancer	8.25e-05	0.000255	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—IL6—ovarian cancer	8.07e-05	0.000249	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—PARP1—ovarian cancer	8.05e-05	0.000249	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CD—ovarian cancer	8.05e-05	0.000249	CbGpPWpGaD
Acitretin—RBP1—Disease—STAT3—ovarian cancer	7.94e-05	0.000245	CbGpPWpGaD
Acitretin—RBP1—Disease—NRAS—ovarian cancer	7.92e-05	0.000245	CbGpPWpGaD
Acitretin—ALB—Hemostasis—SPARC—ovarian cancer	7.9e-05	0.000244	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	7.9e-05	0.000244	CbGpPWpGaD
Acitretin—RXRA—Metabolism—YAP1—ovarian cancer	7.71e-05	0.000238	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	7.63e-05	0.000236	CbGpPWpGaD
Acitretin—RBP1—Disease—MAPK3—ovarian cancer	7.58e-05	0.000234	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MMP2—ovarian cancer	7.57e-05	0.000234	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	7.42e-05	0.000229	CbGpPWpGaD
Acitretin—RBP1—Disease—MYC—ovarian cancer	7.38e-05	0.000228	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—ERBB2—ovarian cancer	7.29e-05	0.000225	CbGpPWpGaD
Acitretin—RBP1—Disease—MAPK1—ovarian cancer	7.22e-05	0.000223	CbGpPWpGaD
Acitretin—RBP1—Disease—EGFR—ovarian cancer	7.22e-05	0.000223	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MTOR—ovarian cancer	7.19e-05	0.000222	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CB—ovarian cancer	7.19e-05	0.000222	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CB—ovarian cancer	7.01e-05	0.000217	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	6.97e-05	0.000216	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CXCL8—ovarian cancer	6.91e-05	0.000214	CbGpPWpGaD
Acitretin—RBP1—Disease—KRAS—ovarian cancer	6.82e-05	0.000211	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CDKN1B—ovarian cancer	6.75e-05	0.000209	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.71e-05	0.000207	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—ERBB2—ovarian cancer	6.64e-05	0.000205	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CASP3—ovarian cancer	6.62e-05	0.000204	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IL2—ovarian cancer	6.61e-05	0.000204	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—PPP2R1A—ovarian cancer	6.53e-05	0.000202	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	6.52e-05	0.000202	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CCND1—ovarian cancer	6.44e-05	0.000199	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	6.44e-05	0.000199	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—IL6—ovarian cancer	6.41e-05	0.000198	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CTNNB1—ovarian cancer	6.38e-05	0.000197	CbGpPWpGaD
Acitretin—RXRA—Metabolism—FASN—ovarian cancer	6.29e-05	0.000194	CbGpPWpGaD
Acitretin—RBP1—Disease—PIK3CA—ovarian cancer	6.26e-05	0.000194	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MMP9—ovarian cancer	6.25e-05	0.000193	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PTEN—ovarian cancer	6.22e-05	0.000192	CbGpPWpGaD
Acitretin—RXRA—Metabolism—SLC5A5—ovarian cancer	6.18e-05	0.000191	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PTEN—ovarian cancer	6.06e-05	0.000187	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	6.02e-05	0.000186	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYTB—ovarian cancer	6e-05	0.000185	CbGpPWpGaD
Acitretin—RXRA—Metabolism—SLC2A1—ovarian cancer	5.97e-05	0.000185	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	5.86e-05	0.000181	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.85e-05	0.000181	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	5.82e-05	0.00018	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—CTNNB1—ovarian cancer	5.81e-05	0.000179	CbGpPWpGaD
Acitretin—RBP1—Disease—HRAS—ovarian cancer	5.79e-05	0.000179	CbGpPWpGaD
Acitretin—ALB—Hemostasis—SOD1—ovarian cancer	5.74e-05	0.000177	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP1B1—ovarian cancer	5.73e-05	0.000177	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PPP2R1A—ovarian cancer	5.71e-05	0.000177	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MMP9—ovarian cancer	5.69e-05	0.000176	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	5.68e-05	0.000176	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—VEGFA—ovarian cancer	5.61e-05	0.000174	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—STAT3—ovarian cancer	5.56e-05	0.000172	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—NRAS—ovarian cancer	5.55e-05	0.000171	CbGpPWpGaD
Acitretin—RBP1—Disease—IL6—ovarian cancer	5.55e-05	0.000171	CbGpPWpGaD
Acitretin—RARG—Gene Expression—MAPK3—ovarian cancer	5.52e-05	0.000171	CbGpPWpGaD
Acitretin—RARG—Gene Expression—MYC—ovarian cancer	5.37e-05	0.000166	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MAPK3—ovarian cancer	5.31e-05	0.000164	CbGpPWpGaD
Acitretin—ALB—Metabolism—PPP1CC—ovarian cancer	5.24e-05	0.000162	CbGpPWpGaD
Acitretin—ALB—Metabolism—BRIP1—ovarian cancer	5.24e-05	0.000162	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	5.22e-05	0.000161	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MYC—ovarian cancer	5.17e-05	0.00016	CbGpPWpGaD
Acitretin—RBP1—Disease—AKT1—ovarian cancer	5.12e-05	0.000158	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—VEGFA—ovarian cancer	5.11e-05	0.000158	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PPP2R1A—ovarian cancer	5.08e-05	0.000157	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—STAT3—ovarian cancer	5.06e-05	0.000156	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MAPK1—ovarian cancer	5.05e-05	0.000156	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.05e-05	0.000156	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—EGFR—ovarian cancer	5.05e-05	0.000156	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—NRAS—ovarian cancer	5.05e-05	0.000156	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—MAPK3—ovarian cancer	5.05e-05	0.000156	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—MYC—ovarian cancer	5e-05	0.000154	CbGpPWpGaD
Acitretin—RARB—Gene Expression—MAPK3—ovarian cancer	4.95e-05	0.000153	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—MYC—ovarian cancer	4.91e-05	0.000152	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MAPK3—ovarian cancer	4.83e-05	0.000149	CbGpPWpGaD
Acitretin—RARB—Gene Expression—MYC—ovarian cancer	4.81e-05	0.000149	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—KRAS—ovarian cancer	4.77e-05	0.000148	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—MAPK3—ovarian cancer	4.75e-05	0.000147	CbGpPWpGaD
Acitretin—RARA—Gene Expression—MAPK3—ovarian cancer	4.75e-05	0.000147	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ABCB1—ovarian cancer	4.72e-05	0.000146	CbGpPWpGaD
Acitretin—RXRA—Metabolism—TYMS—ovarian cancer	4.63e-05	0.000143	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—ESR1—ovarian cancer	4.62e-05	0.000143	CbGpPWpGaD
Acitretin—RARA—Gene Expression—MYC—ovarian cancer	4.62e-05	0.000143	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—MYC—ovarian cancer	4.62e-05	0.000143	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MAPK1—ovarian cancer	4.6e-05	0.000142	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—EGFR—ovarian cancer	4.6e-05	0.000142	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	4.59e-05	0.000142	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	4.44e-05	0.000137	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CA—ovarian cancer	4.39e-05	0.000136	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—KRAS—ovarian cancer	4.34e-05	0.000134	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CA—ovarian cancer	4.28e-05	0.000132	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TP53—ovarian cancer	4.24e-05	0.000131	CbGpPWpGaD
Acitretin—ALB—Hemostasis—CAV1—ovarian cancer	4.2e-05	0.00013	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	4.2e-05	0.00013	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—HRAS—ovarian cancer	4.06e-05	0.000125	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	3.99e-05	0.000123	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IL6—ovarian cancer	3.88e-05	0.00012	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CG—ovarian cancer	3.82e-05	0.000118	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.82e-05	0.000118	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CAV1—ovarian cancer	3.73e-05	0.000115	CbGpPWpGaD
Acitretin—RARG—Gene Expression—AKT1—ovarian cancer	3.72e-05	0.000115	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—HRAS—ovarian cancer	3.69e-05	0.000114	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—AKT1—ovarian cancer	3.58e-05	0.000111	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.56e-05	0.00011	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—IL6—ovarian cancer	3.53e-05	0.000109	CbGpPWpGaD
Acitretin—ALB—Metabolism—YAP1—ovarian cancer	3.52e-05	0.000109	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—AKT1—ovarian cancer	3.49e-05	0.000108	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.48e-05	0.000108	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	3.46e-05	0.000107	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—AKT1—ovarian cancer	3.4e-05	0.000105	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CG—ovarian cancer	3.4e-05	0.000105	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CD—ovarian cancer	3.36e-05	0.000104	CbGpPWpGaD
Acitretin—RARB—Gene Expression—AKT1—ovarian cancer	3.34e-05	0.000103	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—AKT1—ovarian cancer	3.26e-05	0.000101	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—AKT1—ovarian cancer	3.2e-05	9.89e-05	CbGpPWpGaD
Acitretin—RARA—Gene Expression—AKT1—ovarian cancer	3.2e-05	9.89e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.06e-05	9.46e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CD—ovarian cancer	2.99e-05	9.23e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CB—ovarian cancer	2.93e-05	9.05e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—FASN—ovarian cancer	2.87e-05	8.86e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	2.83e-05	8.75e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SLC5A5—ovarian cancer	2.82e-05	8.72e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SLC2A1—ovarian cancer	2.72e-05	8.42e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IL2—ovarian cancer	2.69e-05	8.31e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.67e-05	8.24e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP1B1—ovarian cancer	2.61e-05	8.07e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CB—ovarian cancer	2.6e-05	8.05e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—MAPK3—ovarian cancer	2.47e-05	7.64e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—MYC—ovarian cancer	2.41e-05	7.43e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PPP2R1A—ovarian cancer	2.32e-05	7.16e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.3e-05	7.12e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—VEGFA—ovarian cancer	2.29e-05	7.07e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—NRAS—ovarian cancer	2.26e-05	6.98e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTEN—ovarian cancer	2.25e-05	6.95e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—MAPK3—ovarian cancer	2.16e-05	6.68e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ABCB1—ovarian cancer	2.15e-05	6.65e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—TYMS—ovarian cancer	2.11e-05	6.53e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—MAPK1—ovarian cancer	2.06e-05	6.36e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—KRAS—ovarian cancer	1.94e-05	6.01e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CA—ovarian cancer	1.79e-05	5.52e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TP53—ovarian cancer	1.73e-05	5.34e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CAV1—ovarian cancer	1.7e-05	5.26e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—AKT1—ovarian cancer	1.67e-05	5.15e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—HRAS—ovarian cancer	1.65e-05	5.11e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.63e-05	5.02e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CA—ovarian cancer	1.59e-05	4.91e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CG—ovarian cancer	1.55e-05	4.79e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—AKT1—ovarian cancer	1.46e-05	4.51e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CD—ovarian cancer	1.36e-05	4.21e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—AKT1—ovarian cancer	1.3e-05	4.01e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CB—ovarian cancer	1.19e-05	3.67e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTEN—ovarian cancer	1.03e-05	3.17e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CA—ovarian cancer	7.24e-06	2.24e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—AKT1—ovarian cancer	5.92e-06	1.83e-05	CbGpPWpGaD
